WO2006120565A3 - Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l'eugenol, le thymol, le borneol, le carvacrol, et les i0n0nes alpha- et beta-. - Google Patents
Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l'eugenol, le thymol, le borneol, le carvacrol, et les i0n0nes alpha- et beta-. Download PDFInfo
- Publication number
- WO2006120565A3 WO2006120565A3 PCT/IB2006/001329 IB2006001329W WO2006120565A3 WO 2006120565 A3 WO2006120565 A3 WO 2006120565A3 IB 2006001329 W IB2006001329 W IB 2006001329W WO 2006120565 A3 WO2006120565 A3 WO 2006120565A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- active substance
- carveol
- carvacrol
- borneol
- thymol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06744740A EP1879654B1 (fr) | 2005-05-13 | 2006-05-15 | Combinaison pharmaceutique comprenant un agent antifongique et un actif qui est notamment l'eugénol ou le carvacrol |
BRPI0610132A BRPI0610132B8 (pt) | 2005-05-13 | 2006-05-15 | composição farmacêutica, kit e utilização de uma composição |
CN2006800164908A CN101189044B (zh) | 2005-05-13 | 2006-05-15 | 包含一种抗真菌剂以及一种选自丁香酚、麝香草酚和香芹酚的活性物质的药物组合物 |
JP2008510670A JP5410747B2 (ja) | 2005-05-13 | 2006-05-15 | 抗真菌剤およびカルベオール、オイゲノール、チモール、ボルネオール、カルバクロール、ならびにアルファ−およびベータ−イオノンから選択される活性物質を含んでなる製薬組成物 |
US11/914,005 US20080214568A1 (en) | 2005-05-13 | 2006-05-15 | Pharmaceutical Combination Comprising an Antifungal Agent and an Active Substance Selected From Carveol, Eugenol, Thymol, Borneol, Carvacrol, and Alpha- and Beta-Ionones |
ES06744740T ES2390472T3 (es) | 2005-05-13 | 2006-05-15 | Combinación farmacéutica que comprende un agente antifúngico y un principio activo que es especialmente eugenol o carvacrol |
EA200702482A EA014068B1 (ru) | 2005-05-13 | 2006-05-15 | Фармацевтическая композиция, содержащая противогрибковый агент и активный ингредиент, выбранный из карвеола, тимола, эвгенола и карвакрола |
CA2607561A CA2607561C (fr) | 2005-05-13 | 2006-05-15 | Composition pharmaceutique |
DK06744740.9T DK1879654T3 (da) | 2005-05-13 | 2006-05-15 | Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol |
TNP2007000425A TNSN07425A1 (fr) | 2005-05-13 | 2007-11-13 | Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol,l'eugenol, le thymol, le borneol, le carvacrol, et les ionones alpha-et-beta-. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IBPCT/IB2005/001317 | 2005-05-13 | ||
PCT/IB2005/001317 WO2006120496A1 (fr) | 2005-05-13 | 2005-05-13 | Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l’ eugenol, le thymol, le borneol, et le carvacrol |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006120565A2 WO2006120565A2 (fr) | 2006-11-16 |
WO2006120565A3 true WO2006120565A3 (fr) | 2007-08-23 |
Family
ID=35427301
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/001317 WO2006120496A1 (fr) | 2005-05-13 | 2005-05-13 | Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l’ eugenol, le thymol, le borneol, et le carvacrol |
PCT/IB2006/001329 WO2006120565A2 (fr) | 2005-05-13 | 2006-05-15 | Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l'eugenol, le thymol, le borneol, le carvacrol, et les i0n0nes alpha- et beta-. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/001317 WO2006120496A1 (fr) | 2005-05-13 | 2005-05-13 | Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l’ eugenol, le thymol, le borneol, et le carvacrol |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080214568A1 (fr) |
EP (1) | EP1879654B1 (fr) |
JP (1) | JP5410747B2 (fr) |
CN (1) | CN101189044B (fr) |
BR (1) | BRPI0610132B8 (fr) |
CA (1) | CA2607561C (fr) |
DK (1) | DK1879654T3 (fr) |
EA (1) | EA014068B1 (fr) |
ES (1) | ES2390472T3 (fr) |
MA (1) | MA29907B1 (fr) |
PT (1) | PT1879654E (fr) |
TN (1) | TNSN07425A1 (fr) |
WO (2) | WO2006120496A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007003773A (es) | 2004-09-28 | 2009-01-19 | Chemaphor Inc | Composiciones y metodos para promover ganancia de peso y conversion de alimentacion. |
WO2009052629A1 (fr) * | 2007-10-26 | 2009-04-30 | Chemaphor Inc. | Compositions et procédés pour améliorer la réponse immunitaire |
AU2010242502B2 (en) | 2009-04-30 | 2016-11-10 | Avivagen Inc. | Methods and compositions for improving the health of animals |
WO2011036048A1 (fr) | 2009-09-24 | 2011-03-31 | Unilever Nv | Agent désinfectant comprenant de l'eugénol, du terpinéol et du thymol |
BR112013013085B1 (pt) | 2010-12-07 | 2018-02-14 | Unilever N.V. | Composição de cuidados orais, enxaguante bucal, creme dental, dentífrico, método para desinfetar a cavidade oral e uso de uma composição |
CN102550610B (zh) * | 2010-12-07 | 2014-12-10 | 菲勒斯株式会社 | 含有从红松球果中提取的植物杀菌素的天然抗菌剂及包含它的水果病害防除原料 |
US20130310452A1 (en) * | 2011-02-07 | 2013-11-21 | Firmenich Sa | Antifungal flavouring ingredients and compositions |
EA024551B1 (ru) | 2011-11-03 | 2016-09-30 | Юнилевер Н.В. | Индивидуальная композиция для очищения |
JP5925605B2 (ja) * | 2012-06-04 | 2016-05-25 | 花王株式会社 | リパーゼ活性阻害剤、抗真菌剤、及びフケ抑制剤 |
IL251588B1 (en) | 2014-10-08 | 2024-05-01 | Pacific Northwest Res Institute | Methods and preparations for increasing the potency of antifungal agents |
CN104642326B (zh) * | 2015-02-16 | 2016-02-10 | 河南科技学院 | 一种含戊苯吡菌胺和香芹酚的杀菌组合物及其用途 |
JP7033586B2 (ja) | 2016-06-02 | 2022-03-10 | アドバンスト サイエンティフィック ディヴェロップメンツ | シネオールとアモキシシリンとを含む医薬製剤 |
EP3490552B1 (fr) | 2016-07-26 | 2022-11-23 | University of Southern California | Inhibition sélective de bromodomaine de bdf1 fongique |
CN113116916B (zh) * | 2021-05-25 | 2023-07-04 | 河北医科大学第二医院 | 一种治疗妇科疾病的药物组合物及其制备方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996040192A1 (fr) * | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Utilisation d'huiles essentielles pour accroitre la biodisponibilite des composes pharmaceutiques oraux |
WO2001015680A1 (fr) * | 1999-09-01 | 2001-03-08 | Van Beek Global/Ninkov L.L.C. | Composition destinee au traitement d'infections chez des etres humains et des animaux |
WO2002056879A1 (fr) * | 2001-01-03 | 2002-07-25 | Medpharma Plc | Utilisation de terpenes dans le traitement des infections du tube digestif |
JP2002363070A (ja) * | 2001-06-06 | 2002-12-18 | Yuutoku Yakuhin Kogyo Kk | 経皮吸収貼付剤 |
US20030064948A1 (en) * | 2001-02-08 | 2003-04-03 | Alfred Fahr | Invasomes for therapy of disorders, their preparation and use |
WO2003049726A1 (fr) * | 2001-12-07 | 2003-06-19 | Eden Research Plc | Prophylaxie et traitement des infections respiratoires avec des compositions contenant du terpene |
US20030225003A1 (en) * | 2002-04-18 | 2003-12-04 | Dusan Ninkov | Antimicrobial therapeutic compositions for oral and topical use |
WO2004070017A2 (fr) * | 2003-02-04 | 2004-08-19 | Bennes, Inc. | Formes galeniques aromatisees de longue duree pour la liberation prolongee d'agents benefiques dans la bouche |
WO2004089357A2 (fr) * | 2003-04-02 | 2004-10-21 | Regents Of The University Of Minnesota | Preparation antifongique a base de triterpene et d'huile essentielle |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5294645A (en) * | 1993-06-14 | 1994-03-15 | Doyle E. Chastain | Using menth-1-en-9-ol to kill bacteria, yeast, and fungi |
CA2106032C (fr) * | 1993-09-13 | 1995-11-07 | Gamini Weeratunga | Methodes pour la fabrication de la fluoconazole et de ses derives, composes intermediaires utiles pour leur fabrication, et combinaisons comportant de la fluoconazole |
CN1112933C (zh) * | 1994-01-14 | 2003-07-02 | 爱克索马技术有限公司 | 抗真菌的方法和物质 |
US6319507B1 (en) * | 1997-05-02 | 2001-11-20 | Kobo Products, Inc. | Agar gel bead composition and method |
JP2002284702A (ja) * | 2001-01-19 | 2002-10-03 | Teika Seiyaku Kk | 外用抗真菌製剤 |
US20040071757A1 (en) * | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
-
2005
- 2005-05-13 WO PCT/IB2005/001317 patent/WO2006120496A1/fr active Application Filing
-
2006
- 2006-05-15 PT PT06744740T patent/PT1879654E/pt unknown
- 2006-05-15 ES ES06744740T patent/ES2390472T3/es active Active
- 2006-05-15 CN CN2006800164908A patent/CN101189044B/zh not_active Expired - Fee Related
- 2006-05-15 JP JP2008510670A patent/JP5410747B2/ja not_active Expired - Fee Related
- 2006-05-15 US US11/914,005 patent/US20080214568A1/en not_active Abandoned
- 2006-05-15 DK DK06744740.9T patent/DK1879654T3/da active
- 2006-05-15 CA CA2607561A patent/CA2607561C/fr not_active Expired - Fee Related
- 2006-05-15 BR BRPI0610132A patent/BRPI0610132B8/pt not_active IP Right Cessation
- 2006-05-15 EP EP06744740A patent/EP1879654B1/fr active Active
- 2006-05-15 WO PCT/IB2006/001329 patent/WO2006120565A2/fr active Application Filing
- 2006-05-15 EA EA200702482A patent/EA014068B1/ru not_active IP Right Cessation
-
2007
- 2007-11-13 TN TNP2007000425A patent/TNSN07425A1/fr unknown
- 2007-12-28 MA MA30529A patent/MA29907B1/fr unknown
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996040192A1 (fr) * | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Utilisation d'huiles essentielles pour accroitre la biodisponibilite des composes pharmaceutiques oraux |
WO2001015680A1 (fr) * | 1999-09-01 | 2001-03-08 | Van Beek Global/Ninkov L.L.C. | Composition destinee au traitement d'infections chez des etres humains et des animaux |
WO2002056879A1 (fr) * | 2001-01-03 | 2002-07-25 | Medpharma Plc | Utilisation de terpenes dans le traitement des infections du tube digestif |
US20030064948A1 (en) * | 2001-02-08 | 2003-04-03 | Alfred Fahr | Invasomes for therapy of disorders, their preparation and use |
JP2002363070A (ja) * | 2001-06-06 | 2002-12-18 | Yuutoku Yakuhin Kogyo Kk | 経皮吸収貼付剤 |
WO2003049726A1 (fr) * | 2001-12-07 | 2003-06-19 | Eden Research Plc | Prophylaxie et traitement des infections respiratoires avec des compositions contenant du terpene |
US20030225003A1 (en) * | 2002-04-18 | 2003-12-04 | Dusan Ninkov | Antimicrobial therapeutic compositions for oral and topical use |
WO2004070017A2 (fr) * | 2003-02-04 | 2004-08-19 | Bennes, Inc. | Formes galeniques aromatisees de longue duree pour la liberation prolongee d'agents benefiques dans la bouche |
WO2004089357A2 (fr) * | 2003-04-02 | 2004-10-21 | Regents Of The University Of Minnesota | Preparation antifongique a base de triterpene et d'huile essentielle |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Week 200382, Derwent World Patents Index; AN 2003-880974, XP002438179 * |
HUSSAIN, AZHAR A. ET AL: "Antifungal activity of Egyptian essential oils against some dermatophytes", AFRICAN JOURNAL OF MYCOLOGY AND BIOTECHNOLOGY (2003), 11(2), 1-20 CODEN: AJMBFV; ISSN: 1110-5879, 2003, XP008056733 * |
Also Published As
Publication number | Publication date |
---|---|
TNSN07425A1 (fr) | 2009-03-17 |
CA2607561A1 (fr) | 2006-11-16 |
WO2006120565A2 (fr) | 2006-11-16 |
CN101189044A (zh) | 2008-05-28 |
WO2006120496A1 (fr) | 2006-11-16 |
CA2607561C (fr) | 2014-02-04 |
EA014068B1 (ru) | 2010-08-30 |
BRPI0610132B8 (pt) | 2021-05-25 |
US20080214568A1 (en) | 2008-09-04 |
EP1879654B1 (fr) | 2012-07-04 |
DK1879654T3 (da) | 2012-08-20 |
BRPI0610132B1 (pt) | 2020-08-11 |
JP5410747B2 (ja) | 2014-02-05 |
EP1879654A2 (fr) | 2008-01-23 |
MA29907B1 (fr) | 2008-11-03 |
EA200702482A1 (ru) | 2008-04-28 |
BRPI0610132A2 (pt) | 2012-09-25 |
PT1879654E (pt) | 2012-08-29 |
JP2008540506A (ja) | 2008-11-20 |
CN101189044B (zh) | 2011-12-07 |
ES2390472T3 (es) | 2012-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006120565A3 (fr) | Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l'eugenol, le thymol, le borneol, le carvacrol, et les i0n0nes alpha- et beta-. | |
WO2006120567A3 (fr) | Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol | |
AP2437A (en) | Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected fromcarveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone | |
AP2008004525A0 (en) | Compositions and methods comprising terpene mixtures selected from thymol, eugenol, geraniol, citral, and L-carvone | |
CL2018003398A1 (es) | Composición farmacéutica de liberación sostenida que comprende micro-partículas. (divisional de solicitud 2013-03538). | |
WO2006127601A3 (fr) | Composition de confiserie contenant un composant elastomere, un composant saccharide cuit et un composant a liberation modifiee | |
EP2368871B8 (fr) | Procédé d'élaboration de (1R,2R)-3-(3-diméthylamino-1-éthyl-2-méthyl-propyl)-phénol | |
WO2009137391A3 (fr) | Composés de benzène sulfonamide thiazole et oxazole | |
WO2007134279A3 (fr) | Compositions de n-[2,4-bis(1,1-diméthyléthyl)-5-hydroxyphényl]-1,4-dihydro-4-oxoquinoléine-3-carboxamide | |
WO2008037421A3 (fr) | Composés organiques | |
WO2007042271A3 (fr) | Nouvelle utilisation de compositions nutraceutiques | |
WO2010056022A3 (fr) | Antagonistes de récepteur de mélanocortine | |
BRPI0512792A (pt) | formas cristalinas sólidas de cloridrato de ( - ) - (1r, 2r) - 3 - (3-dimetilamino-1-etil-2-metilpropil) - fenol | |
WO2009099670A3 (fr) | Conjugués d'oligomère et de cannabinoïde | |
IL193720A0 (en) | Pesticide compositions for combating arthropod pests, snails and nematodes | |
WO2008065316A3 (fr) | Compositions sous forme d'onguent comprenant un derive de vitamine d | |
WO2007137131A3 (fr) | Administration d'agents actifs au moyen d'un excipient au chocolat | |
NO20090797L (no) | Farmasoytiske blandinger omfattende kandesartan cileksetil | |
WO2007057748A3 (fr) | Utilisation du colostrum pour la prophylaxie des syndromes grippaux | |
WO2007067784A3 (fr) | Compositions liposomales | |
WO2007009691A3 (fr) | Combinaison de substances active s | |
WO2007135523A3 (fr) | Composition destinée à inactiver un virus enveloppé | |
WO2008006575A3 (fr) | Procédé destiné à produire des aklylanilides à partir de dérivés d'halogénobenzènes | |
WO2008076483A3 (fr) | Optimisation glycopeptidique rapide utilisant la néoglycosylation | |
WO2007009989A3 (fr) | COMPOSITION COMPRENANT UNE DISPERSION LIPOSOMALE DE NANOPARTICULES DE SIO2 ET UN DERIVE D'ETHER DE GLUCANE A LIAISON ß-1,3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006744740 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2607561 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008510670 Country of ref document: JP Ref document number: 200680016490.8 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4483/KOLNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200702482 Country of ref document: EA Ref document number: DZP2007000784 Country of ref document: DZ |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11914005 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2006744740 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0610132 Country of ref document: BR Kind code of ref document: A2 Effective date: 20071113 |